Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 09, 2026
DataAggregated Company Financials
Companies7
- 7D-10.9%
- 3M5.9%
- 1Y-18.6%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 11%, driven by a pullback from Oxford Nanopore Technologies of 13%. In contrast, IXICO has gained 10%. However, the industry is down 19% over the past year. Looking forward, earnings are forecast to grow by 57% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 09 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1252.6x | -8x | 4.1x |
| Sat, 06 Jun 2026 | UK£1.5b | UK£323.0m | -UK£166,018,254.00 | 1235.1x | -9x | 4.6x |
| Mon, 04 May 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.2x | 4.3x |
| Wed, 01 Apr 2026 | UK£1.3b | UK£323.0m | -UK£156,192,254.00 | 8.1x | -8.2x | 3.9x |
| Fri, 27 Feb 2026 | UK£1.5b | UK£304.7m | -UK£159,511,254.00 | 11x | -9.6x | 5x |
| Sun, 25 Jan 2026 | UK£1.9b | UK£304.6m | -UK£159,441,254.00 | 7.5x | -11.8x | 6.2x |
| Tue, 23 Dec 2025 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.4x | -9.1x | 4.8x |
| Thu, 20 Nov 2025 | UK£1.4b | UK£304.3m | -UK£163,156,254.00 | 7.6x | -8.7x | 4.6x |
| Sat, 18 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 9.1x | -9.8x | 5.2x |
| Mon, 15 Sep 2025 | UK£1.8b | UK£313.5m | -UK£158,190,352.00 | 6.2x | -11.4x | 5.8x |
| Wed, 13 Aug 2025 | UK£2.3b | UK£291.9m | -UK£160,968,352.00 | 7x | -14.1x | 7.8x |
| Fri, 11 Jul 2025 | UK£1.7b | UK£291.9m | -UK£160,968,352.00 | 6.5x | -10.4x | 5.7x |
| Sun, 08 Jun 2025 | UK£1.6b | UK£319.4m | -UK£190,824,326.20 | 7x | -8.1x | 4.9x |
| Tue, 06 May 2025 | UK£1.7b | UK£314.0m | -UK£192,459,514.70 | 11.3x | -8.7x | 5.3x |
| Thu, 03 Apr 2025 | UK£1.4b | UK£315.6m | -UK£186,373,071.25 | 4.9x | -7.7x | 4.5x |
| Sat, 01 Mar 2025 | UK£1.6b | UK£306.5m | -UK£195,230,171.52 | 6.4x | -8.2x | 5.2x |
| Mon, 27 Jan 2025 | UK£2.0b | UK£306.8m | -UK£195,467,101.20 | 7.6x | -10.5x | 6.7x |
| Wed, 25 Dec 2024 | UK£1.9b | UK£306.7m | -UK£195,356,319.60 | 7.6x | -9.8x | 6.2x |
| Fri, 22 Nov 2024 | UK£1.7b | UK£306.5m | -UK£193,004,234.48 | 8.9x | -9x | 5.7x |
| Sun, 20 Oct 2024 | UK£2.0b | UK£304.5m | -UK£192,394,470.10 | 11.2x | -10.5x | 6.6x |
| Tue, 17 Sep 2024 | UK£2.0b | UK£301.7m | -UK£190,789,452.50 | 11.1x | -10.7x | 6.8x |
| Thu, 15 Aug 2024 | UK£1.8b | UK£296.6m | -UK£189,019,130.70 | 12.3x | -9.8x | 6.2x |
| Sat, 13 Jul 2024 | UK£1.6b | UK£295.1m | -UK£189,558,138.03 | 11.4x | -8.5x | 5.5x |
| Mon, 10 Jun 2024 | UK£1.6b | UK£295.7m | -UK£189,861,210.03 | 11.4x | -8.4x | 5.4x |
| Wed, 08 May 2024 | UK£1.6b | UK£292.9m | -UK£188,993,040.89 | 6867.6x | -8.3x | 5.4x |
| Fri, 05 Apr 2024 | UK£1.7b | UK£319.1m | -UK£191,357,589.21 | 70.4x | -8.9x | 5.3x |
| Sun, 03 Mar 2024 | UK£1.8b | UK£285.8m | -UK£189,240,511.01 | 6609.8x | -9.6x | 6.4x |
| Tue, 30 Jan 2024 | UK£2.7b | UK£450.2m | -UK£176,570,289.00 | 62.2x | -15.1x | 5.9x |
| Thu, 28 Dec 2023 | UK£3.2b | UK£449.8m | -UK£173,811,154.00 | 54.4x | -18.4x | 7.1x |
| Sat, 25 Nov 2023 | UK£3.0b | UK£455.4m | -UK£168,510,998.00 | 49.9x | -17.8x | 6.6x |
| Mon, 23 Oct 2023 | UK£3.1b | UK£458.7m | -UK£165,641,089.00 | 48.3x | -18.5x | 6.7x |
| Wed, 20 Sep 2023 | UK£3.0b | UK£440.6m | -UK£167,122,892.00 | 67.5x | -18.1x | 6.9x |
| Fri, 18 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,453,796.00 | 70.6x | -24.5x | 6.5x |
| Sun, 16 Jul 2023 | UK£3.0b | UK£475.6m | -UK£124,063,543.00 | 65.2x | -24.4x | 6.4x |
Price to Earnings Ratio
-24.4x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.1x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | -0.23% | |
| Healthcare | 2.58% | |
| Life Sciences | -10.92% | |
| Clinical Research and Equipment | -10.92% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| IXI IXICO | UK£0.091 | 10.3% +UK£1.9m | -6.7% | PS2.7x | |
| OBD Oxford BioDynamics | UK£0.0011 | 22.2% +UK£858.2k | -56.9% | PS3.9x | |
| PRM Proteome Sciences | UK£0.017 | 3.0% +UK£175.4k | -42.2% | PS1.6x |